Literature DB >> 20153542

Comparison of clinical-metabolic monitoring and outcomes and coronary risk status in people with type 2 diabetes from Australia, France and Latin America.

Juan J Gagliardino1, Line Kleinebreil, Stephen Colagiuri, Jeff Flack, Joaquín E Caporale, Fernando Siri, Charles Clark.   

Abstract

AIM: To compare clinical-metabolic monitoring and coronary risk status in people with type 2 diabetes from Australia, France and Latin America.
METHODS: Retrospective analysis of data collected at primary care (except ANDIAB--secondary care) [corrected] matched for age, gender and disease duration. Measurements included participants' characteristics, performance frequency of clinical-metabolic process indicators, and percentage of clinical-metabolic outcomes at recommended target values.
RESULTS: The weighted mean of the percentage of process performance was within 68 to 81%; that of outcomes at target dropped to 29 to 45%. Although statistically significant, differences among groups were far from those in healthcare budgets, and probably only of marginal clinical impact. The percentage of patients with low, slight or high coronary risk was similar in the three groups, with most people at high or very high risk.
CONCLUSIONS: Despite the high difference in health per capita investment and system characteristics among countries, the study populations had striking similarities regarding the low percentage of participants who achieved cardiovascular risk factor and diabetes treatment goals. Therefore, differences in health budget and system characteristics would not be the main drivers in care quality. Diabetes education at every level and quality care registries would contribute to improve this situation and assess such improvement.

Entities:  

Mesh:

Year:  2010        PMID: 20153542     DOI: 10.1016/j.diabres.2009.12.024

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  4 in total

1.  The cost of diabetes in Latin America and the Caribbean in 2015: Evidence for decision and policy makers.

Authors:  Alberto Barcelo; Armando Arredondo; Amparo Gordillo-Tobar; Johanna Segovia; Anthony Qiang
Journal:  J Glob Health       Date:  2017-12       Impact factor: 4.413

2.  First cardiovascular event in patients with type 2 diabetes mellitus of a cardiovascular risk management program of a poor Colombian population: a cohort study.

Authors:  Pablo Miranda-Machado; Fernando Salcedo-Mejía; Justo Paz Wilches; Juan Fernandez-Mercado; Fernando De la Hoz-Restrepo; Nelson Alvis-Guzmán
Journal:  BMC Cardiovasc Disord       Date:  2019-01-08       Impact factor: 2.298

Review 3.  Diabetes in Argentina: cost and management of diabetes and its complications and challenges for health policy.

Authors:  Joaquín E Caporale; Jorge F Elgart; Juan J Gagliardino
Journal:  Global Health       Date:  2013-10-29       Impact factor: 4.185

4.  Challenges associated with insulin therapy progression among patients with type 2 diabetes: Latin American MOSAIc study baseline data.

Authors:  Bruno Linetzky; Brad Curtis; Gustavo Frechtel; Renan Montenegro; Miguel Escalante Pulido; Oded Stempa; Janaina Martins de Lana; Juan José Gagliardino
Journal:  Diabetol Metab Syndr       Date:  2016-07-22       Impact factor: 3.320

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.